News

Pfizer raises 2025 EPS guidance to $2.90–$3.10 while targeting margin expansion through $7.7B cost savings by 2027
Q2 2025 Management View Albert Bourla, Chairman and CEO, highlighted progress in R&D, expansion of the commercial portfolio, and improved margins, stating the company is “raising our adjusted diluted ...
Willis Lease signals continued growth with 29% revenue rise and expanded asset portfolio amid strong engine leasing demand
Q2 2025 Management View Austin Chandler Willis, CEO, highlighted a record-setting quarter, stating “we achieved our highest ...